Immune regulation by glucocorticoids

Nature Reviews Immunology

Volumn 17, Issue 4, 2017, Pages 233-247

  Cain, Derek W ^a   Cidlowski, John A ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOSUPPRESSIVE AGENT;

ANTIBODY PRODUCTION; B LYMPHOCYTE; CELL DEATH; CELL SURVIVAL; GENE CONTROL; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; INFLAMMATION; MOBILIZATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEROIDOGENESIS; T LYMPHOCYTE ACTIVATION; ANIMAL; DRUG EFFECTS; IMMUNE SYSTEM; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; GLUCOCORTICOIDS; HUMANS; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION;

EID: 85012134745     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri.2017.1     Document Type: Review

References (135)

1. Galon, J. et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 16, 61-71 (2002)
2. Miller, W. L. & Auchus, R. J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 32, 81-151 (2011)
3. Talaber, G., Jondal, M. & Okret, S. Extra-adrenal glucocorticoid synthesis: immune regulation and aspects on local organ homeostasis. Mol. Cell. Endocrinol. 380, 89-98 (2013)
4. Dunn, A. J. Cytokine activation of the HPA axis. Ann. NY Acad. Sci. 917, 608-617 (2000)
5. Bornstein, S. R. et al. The role of Toll-like receptors in the immune-adrenal crosstalk. Ann. NY Acad. Sci. 1088, 307-318 (2006)
6. Spiga, F., Walker, J. J., Terry, J. R. & Lightman, S. L. HPA axis-rhythms. Compr. Physiol. 4, 1273-1298 (2014)
7. Scheiermann, C., Kunisaki, Y. & Frenette, P. S. Circadian control of the immune system. Nat. Rev. Immunol. 13, 190-198 (2013)
8. Dimitrov, S. et al. Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood 113, 5134-5143 (2009)
9. Pemberton, P. A., Stein, P. E., Pepys, M. B., Potter, J. M. & Carrell, R. W. Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336, 257-258 (1988)
10. Woodward, M. J. et al. Tnfaip8 is an essential gene for the regulation of glucocorticoid-mediated apoptosis of thymocytes. Cell Death Differ. 17, 316-323 (2010)
11. Patrick, G. History of cortisone and related compounds. eLS http://dx.doi.org/10.1002/9780470015902.a0003627.pub2 (2013)
12. Kumar, R. & Thompson, E. B. Gene regulation by the glucocorticoid receptor: structure:function relationship. J. Steroid Biochem. Mol. Biol. 94, 383-394 (2005)
13. Oakley, R. H. & Cidlowski, J. A. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 286, 3177-3184 (2011)
14. Webster, J. C., Oakley, R. H., Jewell, C. M. & Cidlowski, J. A. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative isoform: A mechanism for the generation of glucocorticoid resistance. Proc. Natl Acad. Sci. USA 98, 6865-6870 (2001)
15. Lu, N. Z. & Cidlowski, J. A. Glucocorticoid receptor isoforms generate transcription specificity. Trends Cell Biol. 16, 301-307 (2006)
16. Vandevyver, S., Dejager, L. & Libert, C. On the trail of the glucocorticoid receptor: into the nucleus and back. Traffic 13, 364-374 (2012)
17. Holaska, J. M. et al. Calreticulin Is a receptor for nuclear export. J. Cell Biol. 152, 127-140 (2001)
18. Strahle, U., Klock, G. & Schutz, G. A. DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc. Natl Acad. Sci. USA 84, 7871-7875 (1987)
19. Luisi, B. F. et al. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352, 497-505 (1991)
20. Surjit, M. et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145, 224-241 (2011)
21. Biddie, S. C., John, S. & Hager, G. L. Genome-wide mechanisms of nuclear receptor action. Trends Endocrinol. Metab. 21, 3-9 (2010)
22. John, S. et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 43, 264-268 (2011)
23. Ratman, D. et al. How glucocorticoid receptors modulate the activity of other transcription factors: A scope beyond tethering. Mol. Cell. Endocrinol. 380, 41-54 (2013)
24. Diamond, M. I., Miner, J. N., Yoshinaga, S. K. & Yamamoto, K. R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249, 1266-1272 (1990)
25. Biddie, S. C. et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 43, 145-155 (2011)
26. Kerppola, T. K., Luk, D. & Curran, T. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol. Cell. Biol. 13, 3782-3791 (1993)
27. Teurich, S. & Angel, P. The glucocorticoid receptor synergizes with Jun homodimers to activate AP-1-regulated promoters lacking GR binding sites. Chem. Senses 20, 251-255 (1994)
28. Lechner, J., Welte, T. & Doppler, W. Mechanism of interaction between the glucocorticoid receptor and Stat5: role of DNA-binding. Immunobiology 198, 112-123 (1997)
29. Tuckermann, J. P. et al. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J. Cell Biol. 147, 1365-1370 (1999)
30. Sundahl, N., Bridelance, J., Libert, C., De Bosscher, K. & Beck, I. M. Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds. Pharmacol. Ther. 152, 28-41 (2015)
31. Coutinho, A. E. & Chapman, K. E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell. Endocrinol. 335, 2-13 (2011)
32. Buttgereit, F. & Scheffold, A. Rapid glucocorticoid effects on immune cells. Steroids 67, 529-534 (2002)
33. Boldizsar, F. et al. Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells. Immunobiology 215, 521-526 (2010)
34. Sionov, R. V., Cohen, O., Kfir, S., Zilberman, Y. & Yefenof, E. Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis. J. Exp. Med. 203, 189-201 (2006)
35. Miyata, M. et al. Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M. Nat. Commun. 6, 6062 (2015)
36. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K. & Baldwin, A. S. Jr. Role of transcriptional activation of IB in mediation of immunosuppression by glucocorticoids. Science 270, 283-286 (1995)
37. Heck, S. et al. IB-independent downregulation of NF-B activity by glucocorticoid receptor. EMBO J. 16, 4698-4707 (1997)
38. Beaulieu, E. & Morand, E. F. Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis. Nat. Rev. Rheumatol. 7, 340-348 (2011)
39. Guiducci, C. et al. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 465, 937-941 (2010)
40. Oppong, E., Flink, N. & Cato, A. C. Molecular mechanisms of glucocorticoid action in mast cells. Mol. Cell. Endocrinol. 380, 119-126 (2013)
41. Kim, S. W. et al. Inhibition of cytosolic phospholipase A2 by annexin I. Specific interaction model and mapping of the interaction site. J. Biol. Chem. 276, 15712-15719 (2001)
42. Yang, N., Zhang, W. & Shi, X. M. Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression. J. Cell. Biochem. 103, 1760-1771 (2008)
43. Perretti, M. & Ahluwalia, A. The microcirculation and inflammation: site of action for glucocorticoids. Microcirculation 7, 147-161 (2000)
44. Vettorazzi, S. et al. Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. Nat. Commun. 6, 7796 (2015)
45. Gottlicher, M., Heck, S. & Herrlich, P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76, 480-489 (1998)
46. Smoak, K. & Cidlowski, J. A. Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling. Mol. Cell. Biol. 26, 9126-9135 (2006)
47. Rogatsky, I. & Ivashkiv, L. B. Glucocorticoid modulation of cytokine signaling. Tissue Antigens 68, 1-12 (2006)
48. Bhattacharyya, S., Zhao, Y., Kay, T. W. & Muglia, L. J. Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation. Proc. Natl Acad. Sci. USA 108, 9554-9559 (2011)
49. Kleiman, A. et al. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J. 26, 722-729 (2012)
50. Bhattacharyya, S., Brown, D. E., Brewer, J. A., Vogt, S. K. & Muglia, L. J. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109, 4313-4319 (2007)
51. Li, C. C., Munitic, I., Mittelstadt, P. R., Castro, E. & Ashwell, J. D. Suppression of dendritic cell-derived IL-12 by endogenous glucocorticoids is protective in LPS-induced sepsis. PLoS Biol. 13, e1002269 (2015)
52. Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159-175 (2013)
53. Cronstein, B. N., Kimmel, S. C., Levin, R. I., Martiniuk, F. & Weissmann, G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc. Natl Acad. Sci. USA 89, 9991-9995 (1992)
54. Atsuta, J., Plitt, J., Bochner, B. S. & Schleimer, R. P. Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. Am. J. Respir. Cell Mol. Biol. 20, 643-650 (1999)
55. Ishmael, F. T. et al. The human glucocorticoid receptor as an RNA-binding protein: global analysis of glucocorticoid receptor-associated transcripts and identification of a target RNA motif. J. Immunol. 186, 1189-1198 (2011)
56. Wust, S. et al. Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis. J. Immunol. 180, 8434-8443 (2008)
57. Perretti, M. & Flower, R. J. Annexin 1 and the biology of the neutrophil. J. Leukoc. Biol. 76, 25-29 (2004)
58. Serhan, C. N. & Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197 (2005)
59. Ehrchen, J. et al. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109, 1265-1274 (2007)
60. Giles, K. M. et al. Glucocorticoid augmentation of macrophage capacity for phagocytosis of apoptotic cells is associated with reduced p130Cas expression, loss of paxillin/pyk2 phosphorylation, and high levels of active Rac. J. Immunol. 167, 976-986 (2001)
61. Liu, Y. et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162, 3639-3646 (1999)
62. Martinez, F. O., Sica, A., Mantovani, A. & Locati, M. Macrophage activation and polarization. Front. Biosci. 13, 453-461 (2008)
63. Perretti, M. et al. Endogenous lipid-and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat. Med. 8, 1296-1302 (2002)
64. Purton, J. F. et al. Glucocorticoid receptor deficient thymic and peripheral T cells develop normally in adult mice. Eur. J. Immunol. 32, 3546-3555 (2002)
65. Talaber, G., Tuckermann, J. P. & Okret, S. ACTH controls thymocyte homeostasis independent of glucocorticoids. FASEB J. 29, 2526-2534 (2015)
66. Mittelstadt, P. R., Monteiro, J. P. & Ashwell, J. D. Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness. J. Clin. Invest. 122, 2384-2394 (2012)
67. Herold, M. J., McPherson, K. G. & Reichardt, H. M. Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life Sci. 63, 60-72 (2006)
68. Wang, D., Muller, N., McPherson, K. G. & Reichardt, H. M. Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells. J. Immunol. 176, 1695-1702 (2006)
69. Lu, N. Z., Collins, J. B., Grissom, S. F. & Cidlowski, J. A. Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol. Cell. Biol. 27, 7143-7160 (2007)
70. Kim, K. D., Choe, Y. K., Choe, I. S. & Lim, J. S. Inhibition of glucocorticoid-mediated caspase-independent dendritic cell death by CD40 activation. J. Leukoc. Biol. 69, 426-434 (2001)
71. Druilhe, A., Luv, S. & Pretolani, M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 8, 481-495 (2003)
72. Weinstein, R. S., Jilka, R. L., Parfitt, A. M. & Manolagas, S. C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of the deleterious effects on bone. J. Clin. Invest. 102, 274-282 (1998)
73. Szatmari, I. & Nagy, L. Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. EMBO J. 27, 2353-2362 (2008)
74. Chamorro, S. et al. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J. Immunol. 183, 2984-2994 (2009)
75. Shodell, M., Shah, K. & Siegal, F. P. Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration. Lupus 12, 222-230 (2003)
76. Cao, Y. et al. Glucocorticoid receptor translational isoforms underlie maturational stage-specific glucocorticoid sensitivities of dendritic cells in mice and humans. Blood 121, 1553-1562 (2013)
77. Tsitoura, D. C. & Rothman, P. B. Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells. J. Clin. Invest. 113, 619-627 (2004)
78. Petrillo, M. G. et al. Transcriptional regulation of kinases downstream of the T cell receptor: Another immunomodulatory mechanism of glucocorticoids. BMC Pharmacol. Toxicol. 15, 35 (2014)
79. Lowenberg, M., Verhaar, A. P., van den Brink, G. R. & Hommes, D. W. Glucocorticoid signaling: A nongenomic mechanism for T-cell immunosuppression. Trends Mol. Med. 13, 158-163 (2007)
80. Gillis, S., Crabtree, G. R. & Smith, K. A. Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J. Immunol. 123, 1624-1631 (1979)
81. Elenkov, I. J. Glucocorticoids and the Th1/Th2 balance. Ann. NY Acad. Sci. 1024, 138-146 (2004)
82. Liberman, A. C. et al. The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J. 21, 1177-1188 (2007)
83. Yosef, N. et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature 496, 461-468 (2013)
84. Jones, S. A. et al. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation. J. Autoimmun. 61, 73-80 (2015)
85. Baschant, U. et al. Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. Proc. Natl Acad. Sci. USA 108, 19317-19322 (2011)
86. Karagiannidis, C. et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J. Allergy Clin. Immunol. 114, 1425-1433 (2004)
87. Bereshchenko, O. et al. GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF- signaling. Cell Rep. 7, 464-475 (2014)
88. Garvy, B. A., King, L. E., Telford, W. G., Morford, L. A. & Fraker, P. J. Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunology 80, 587-592 (1993)
89. Igarashi, H. et al. Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. Int. Immunol. 17, 501-511 (2005)
90. Gruver-Yates, A. L., Quinn, M. A. & Cidlowski, J. A. Analysis of glucocorticoid receptors and their apoptotic response to dexamethasone in Male murine B cells during development. Endocrinology 155, 463-474 (2014)
91. Jones, S. A. et al. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus. Ann. Rheum. Dis. 75, 739-747 (2016)
92. Bruscoli, S. et al. Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice. Blood 126, 1790-1801 (2015)
93. Posey, W. C., Nelson, H. S., Branch, B. & Pearlman, D. S. The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. J. Allergy Clin. Immunol. 62, 340-348 (1978)
94. Zieg, G., Lack, G., Harbeck, R. J., Gelfand, E. W. & Leung, D. Y. In vivo effects of glucocorticoids on IgE production. J. Allergy Clin. Immunol. 94, 222-230 (1994)
95. Jabara, H. H., Ahern, D. J., Vercelli, D. & Geha, R. S. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J. Immunol. 147, 1557-1560 (1991)
96. Jabara, H. H., Brodeur, S. R. & Geha, R. S. Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching. J. Clin. Invest. 107, 371-378 (2001)
97. Bohle, B. et al. Hydrocortisone enhances total IgE levels - but not the synthesis of allergen-specific IgE - in a monocyte-dependent manner. Clin. Exp. Immunol. 101, 474-479 (1995)
98. Akdis, C. A. et al. Glucocorticoids inhibit human antigen-specific and enhance total IgE and IgG4 production due to differential effects on T and B cells in vitro. Eur. J. Immunol. 27, 2351-2357 (1997)
99. Tuckermann, J. P. et al. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J. Clin. Invest. 117, 1381-1390 (2007)
100. Friedman, E. M. & Irwin, M. Central CRH suppresses specific antibody responses: effects of -adrenoceptor antagonism and adrenalectomy. Brain Behav. Immun. 15, 65-77 (2001)
101. Fleshner, M., Deak, T., Nguyen, K. T., Watkins, L. R. & Maier, S. F. Endogenous glucocorticoids play a positive regulatory role in the anti-keyhole limpet hemocyanin in vivo antibody response. J. Immunol. 166, 3813-3819 (2001)
102. Lim, H. Y., Muller, N., Herold, M. J., van den Brandt, J. & Reichardt, H. M. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology 122, 47-53 (2007)
103. Frank, M. G., Miguel, Z. D., Watkins, L. R. & Maier, S. F. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav. Immun. 24, 19-30 (2010)
104. Dhabhar, F. S. & McEwen, B. S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl Acad. Sci. USA 96, 1059-1064 (1999)
105. van de Garde, M. D. et al. Chronic exposure to glucocorticoids shapes gene expression and modulates innate and adaptive activation pathways in macrophages with distinct changes in leukocyte attraction. J. Immunol. 192, 1196-1208 (2014)
106. Busillo, J. M. & Cidlowski, J. A. The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. Trends Endocrinol. Metab. 24, 109-119 (2013)
107. Wiegers, G. J. & Reul, J. M. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharmacol. Sci. 19, 317-321 (1998)
108. Dhabhar, F. S., Malarkey, W. B., Neri, E. & McEwen, B. S. Stress-induced redistribution of immune cells - from barracks to boulevards to battlefields: A tale of three hormones - Curt Richter Award winner. Psychoneuroendocrinol. 37, 1345-1368 (2012)
109. Dhabhar, F. S. Stress-induced augmentation of immune function - The role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav. Immun. 16, 785-798 (2002)
110. Munck, A. & Naray-Fejes-Toth, A. The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited. Mol. Cell. Endocrinol. 90, C1-C4 (1992)
111. Sapolsky, R. M., Romero, L. M. & Munck, A. U. How do glucocorticoids influence stress responses Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21, 55-89 (2000)
112. Du, J. et al. Dynamic regulation of mitochondrial function by glucocorticoids. Proc. Natl Acad. Sci. USA 106, 3543-3548 (2009)
113. James, E. R. The etiology of steroid cataract. J. Ocul. Pharmacol. Ther. 23, 403-420 (2007)
114. Guslandi, M. & Tittobello, A. Steroid ulcers: A myth revisited. BMJ 304, 655-656 (1992)
115. Cordeiro, R. C., Zecchin, K. G. & de Moraes, A. M. Expression of estrogen, androgen, and glucocorticoid receptors in recent striae distensae. Int. J. Dermatol. 49, 30-32 (2010)
116. Cicala, M. V. & Mantero, F. Hypertension in Cushing's syndrome: from pathogenesis to treatment. Neuroendocrinology 92 (Suppl. 1), 44-49 (2010)
117. Weinstein, R. S. Glucocorticoid-induced osteonecrosis. Endocrine 41, 183-190 (2012)
118. Patel, R., Williams-Dautovich, J. & Cummins, C. L. Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues. Mol. Endocrinol. 28, 999-1011 (2014)
119. Weinstein, R. S. Clinical practice. Glucocorticoid-induced bone disease. N. Engl. J. Med. 365, 62-70 (2011)
120. Guo, S. & Dipietro, L. A. Factors affecting wound healing. J. Dent. Res. 89, 219-229 (2010)
121. Judd, L. L. et al. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am. J. Psychiatry 171, 1045-1051 (2014)
122. Ma, L. et al. CD8+ T cells are predominantly protective and required for effective steroid therapy in murine models of immune thrombocytopenia. Blood 126, 247-256 (2015)
123. Li, L. et al. Role of myeloid-derived suppressor cells in glucocorticoid-mediated amelioration of FSGS. J. Am. Soc. Nephrol. 26, 2183-2197 (2015)
124. Jonat, C. et al. Antitumor promotion and antiinflammation - down-modulation of AP-1 (Fos Jun) activity by glucocorticoid hormone. Cell 62, 1189-1204 (1990)
125. Ki, S. H., Cho, I. J., Choi, D. W. & Kim, S. G. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBP TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression. Mol. Cell. Biol. 25, 4150-4165 (2005)
126. Imai, E., Miner, J. N., Mitchell, J. A., Yamamoto, K. R. & Granner, D. K. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J. Biol. Chem. 268, 5353-5356 (1993)
127. Mullick, J. et al. Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter. J. Biol. Chem. 276, 18007-18017 (2001)
128. Chang, T. J., Scher, B. M., Waxman, S. & Scher, W. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Mol. Endocrinol. 7, 528-542 (1993)
129. Ray, A. & Prefontaine, K. E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-B and the glucocorticoid receptor. Proc. Natl Acad. Sci. USA 91, 752-756 (1994)
130. Martens, C., Bilodeau, S., Maira, M., Gauthier, Y. & Drouin, J. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor. Mol. Endocrinol. 19, 885-897 (2005)
131. Kutoh, E., Stromstedt, P. E. & Poellinger, L. Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1. Mol. Cell. Biol. 12, 4960-4969 (1992)
132. Song, C. Z., Tian, X. & Gelehrter, T. D. Glucocorticoid receptor inhibits transforming growth factor- signaling by directly targeting the transcriptional activation function of Smad3. Proc. Natl Acad. Sci. USA 96, 11776-11781 (1999)
133. Zhang, Z., Jones, S., Hagood, J. S., Fuentes, N. L. & Fuller, G. M. STAT3 acts as a co-activator of glucocorticoid receptor signaling. J. Biol. Chem. 272, 30607-30610 (1997)
134. Stocklin, E., Wissler, M., Gouilleux, F. & Groner, B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 383, 726-728 (1996)
135. Biola, A. et al. The glucocorticoid receptor and STAT6 physically and functionally interact in T-lymphocytes. FEBS Lett. 487, 229-233 (2000).